Reliant Immune Diagnostics

Reliant Immune Diagnostics

Early Stage

Healthcare, Any Time, Anywhere

Healthcare, Any Time, Anywhere


Raised this Round: Raised: $4,052,600



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegD 506(b)    Open SEC Filing

Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Austin, Texas

Reliant Immune Diagnostics is raising funds through Reg D 506(b) raise on MicroVentures. The company has developed a patient-driven health platform that assists in medical care, testing, diagnosing, and monitoring solutions. The platform enables chronic care management, telehealth partner APIs, and a remote physiological monitor. Reliant ID offers an integrated suite of technology, while MDbox is the consumer-facing telehealth app of the business. Henry Legere founded Reliant Immune Diagnostics in 2016. The campaign raised $4,052,600.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Reliant Immune Diagnostics on MicroVentures 2017
Platform: Microventures
Security Type: Equity - Common

Follow company

Follow Reliant Immune Diagnostics on MicroVentures 2017
No Public Offering Page

Buy Reliant Immune Diagnostics's Deal Report

Warning: according to the close date for this deal, Reliant Immune Diagnostics may no longer be accepting investments.

Reliant Immune Diagnostics Deal Report

Get KingsCrowd’s comprehensive report on Reliant Immune Diagnostics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Reliant Immune Diagnostics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Reliant Immune Diagnostics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge